Evaluation of the alkaline comet assay and urinary methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen.

JP Braybrooke; S Houlbrook; JE Crawley; DJ Propper; KJ O'Byrne; IJ Stratford; AL Harris; DEG Shuker; DC. Talbot

Evaluation of the alkaline comet assay and urinary methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen.

JP Braybrooke, S Houlbrook, JE Crawley, DJ Propper, KJ O'Byrne, IJ Stratford, AL Harris, DEG Shuker, DC. Talbot

Research output: Contribution to journal › Article › peer-review

Original language	English
Journal	Br. J. Cancer
Volume	45
Publication status	Published - 2000

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{8dbb8b7c18ce4fc39ade18b15b6906aa,

title = "Evaluation of the alkaline comet assay and urinary methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen.",

author = "JP Braybrooke and S Houlbrook and JE Crawley and DJ Propper and KJ O'Byrne and IJ Stratford and AL Harris and DEG Shuker and DC. Talbot",

year = "2000",

language = "English",

volume = "45",

journal = "Br. J. Cancer",

issn = "1532-1827",

publisher = "Springer Nature",

}

TY - JOUR

T1 - Evaluation of the alkaline comet assay and urinary methyladenine excretion for monitoring DNA damage in melanoma patients treated with dacarbazine and tamoxifen.

AU - Braybrooke, JP

AU - Houlbrook, S

AU - Crawley, JE

AU - Propper, DJ

AU - O'Byrne, KJ

AU - Stratford, IJ

AU - Harris, AL

AU - Shuker, DEG

AU - Talbot, DC.

PY - 2000

Y1 - 2000

M3 - Article

SN - 1532-1827

VL - 45

JO - Br. J. Cancer

JF - Br. J. Cancer

ER -